Rajini Kurup, Keon Flemming, Sudish Daniram, Shenika Marks-James, Roberta Roberts Martin
{"title":"Hematological and Biochemistry Profile and Risk Factors Associated with Pulmonary Tuberculosis Patients in Guyana.","authors":"Rajini Kurup, Keon Flemming, Sudish Daniram, Shenika Marks-James, Roberta Roberts Martin","doi":"10.1155/2016/6983747","DOIUrl":null,"url":null,"abstract":"<p><p>Objective. To evaluate the hematological and biochemistry profile of patients with or without HIV-TB at the Georgetown Chest Clinic, Guyana. Methods. An observational, laboratory based study was designed to assess the relationship of PTB and HIV with patients routine biochemical and hematological values. The study was conducted during the period January 2013 to December 2014; a total sample size of 316 patients was enrolled following exclusion and inclusion criteria. Results. Mean age of study population was 40.1 ± 13.8 (95% CI 38.6-41.7) and most were between 40 and 49 age group (27.8%, 95% CI 23.2-33.0). More males were in the study 74.4% (95% CI 69.3-78.8) than females 81% (95% CI 21.1-30.7). 30% (95% CI 25.3-35.3) had a sputum smear grade of 3+ and 62.5% (95% CI 47.0-75.7) showed a CD4 count <200. The study demonstrated significantly low hemoglobin (Hb) 91.7% (95% CI 78.2-97.1), low WBC 27.8% (95% CI 15.8-44.0), high indirect bilirubin 7.4% (95% CI 2.1-23.3), ALT 41.8% (95% CI 28.4-56.7), and AST 72.2% (95% CI 57.3-83.3) among TB-HIV patients. Homelessness RR (relative risk) 2.2 (95% CI 0.48-12.3), smoking RR 1.09 (95% CI 1.01-1.19), and gender (male) RR 1.2 (95% CI 0.61-2.26) were main associated risk factors. Conclusions. There is slight variation among PTB and PTB-HIV coinfected patients in some hematological and biochemistry parameters. </p>","PeriodicalId":30261,"journal":{"name":"Tuberculosis Research and Treatment","volume":"2016 ","pages":"6983747"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/6983747","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2016/6983747","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/4/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Objective. To evaluate the hematological and biochemistry profile of patients with or without HIV-TB at the Georgetown Chest Clinic, Guyana. Methods. An observational, laboratory based study was designed to assess the relationship of PTB and HIV with patients routine biochemical and hematological values. The study was conducted during the period January 2013 to December 2014; a total sample size of 316 patients was enrolled following exclusion and inclusion criteria. Results. Mean age of study population was 40.1 ± 13.8 (95% CI 38.6-41.7) and most were between 40 and 49 age group (27.8%, 95% CI 23.2-33.0). More males were in the study 74.4% (95% CI 69.3-78.8) than females 81% (95% CI 21.1-30.7). 30% (95% CI 25.3-35.3) had a sputum smear grade of 3+ and 62.5% (95% CI 47.0-75.7) showed a CD4 count <200. The study demonstrated significantly low hemoglobin (Hb) 91.7% (95% CI 78.2-97.1), low WBC 27.8% (95% CI 15.8-44.0), high indirect bilirubin 7.4% (95% CI 2.1-23.3), ALT 41.8% (95% CI 28.4-56.7), and AST 72.2% (95% CI 57.3-83.3) among TB-HIV patients. Homelessness RR (relative risk) 2.2 (95% CI 0.48-12.3), smoking RR 1.09 (95% CI 1.01-1.19), and gender (male) RR 1.2 (95% CI 0.61-2.26) were main associated risk factors. Conclusions. There is slight variation among PTB and PTB-HIV coinfected patients in some hematological and biochemistry parameters.
目标。评估圭亚那乔治城胸科诊所感染或不感染HIV-TB患者的血液学和生物化学特征。方法。一项基于实验室的观察性研究旨在评估PTB和HIV与患者常规生化和血液学值的关系。该研究于2013年1月至2014年12月进行;总样本量为316例患者,遵循排除和纳入标准。结果。研究人群的平均年龄为40.1±13.8岁(95% CI 38.6-41.7),大多数年龄在40 - 49岁之间(27.8%,95% CI 23.2-33.0)。研究中男性占74.4% (95% CI 69.3-78.8),女性占81% (95% CI 21.1-30.7)。30% (95% CI 25.3-35.3)的患者痰涂片分级为3+,62.5% (95% CI 47.0-75.7)的患者有CD4计数